In addition, a double‐blinded, placebo‐controlled, randomized, phase III trial found that, despite the possible interference of losartan on VEGF‐mediated angiogenesis, its use did not show any impact on steroid requirements during radiotherapy to reduce peritumoral edema in newly diagnosed glioblastoma patients.38 Here, VEGFA is linked to glioblastoma.